Ophthalmic Complications Associated With...

Interview with Rupesh Agrawal, MMed, MD, and James T. Rosenbaum, MD, authors of Standardization of Retinal Vasculitis Terminology With Consensus Definitions From a Delphi Panel. Hosted by Neil Bressler, MD. Related Content: Standardization of Retinal Vasculitis Terminology With C ... Show More

Interview with Iqbal Ike K. Ahmed, MD, and Jawad Muayad, MD, authors of Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension. Hosted by Neil Bressler, MD. Related Content: Nicotinamide Supplementation and Primary Open-Angle Glaucoma in ... Show More

Interview with Rishi P. Singh, MD, author The Retina Clinic as a Window Into Systemic Vascular Health. Hosted by Neil Bressler, MD. Related Content: The Retina Clinic as a Window Into Systemic Vascular Health 

Dr. Peter Quiros joins host Dr. Amanda Redfern to discuss the recent JAMA Ophthalmology article "The Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," the first study to report a possible association between semaglutide (Wegovy, Ozempic, ... Show More

Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ... Show More

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights ar ... Show More

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 

On this podcast episode, I discuss the pharmacology, adverse effects, and drug interactions of semaglutide. Semaglutide has two primary uses: Type 2 diabetes and Weight Management – the dosing varies depending upon the indication. When using semaglutide, pay attention to GI adver ... Show More

Interview with Fasiha Kanwal, MD, MSHS, author of GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Hosted by Eve Rittenberg, MD, and Grace Yuan Zhang, MD Related Content: GLP-1 Rece ... Show More

What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?Sponsors: Post Investment: Real Estate Syndications || Hellofresh Show Notes & Transcript02:08 Framework f ... Show More

<p class="MsoNormal">In this special edition of <em>Diabetes Core Update</em>, host Neil Skolnik, MD, explores the timely and critical topic of compounded medications in diabetes care. In this episode Dr. Skolnik moderates a discussion between a family doctor, a patient, and a ph ... Show More

<p class="MsoNormal">Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their <em>Ophthalmology Glaucoma</em> article, "<a href= "https://www.ophthalmologyglaucoma.org/ ... Show More